The Neuro-Ischaemic Charcot Foot: Prevalence, Characteristics and Severity of Peripheral Arterial Disease in Acute Charcot Neuro-Arthropathy.
Charcot neuro-arthropathy
diabetes
diabetic foot
peripheral arterial disease
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
22 Oct 2022
22 Oct 2022
Historique:
received:
04
09
2022
revised:
12
10
2022
accepted:
17
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
The study aimed to evaluate the prevalence, characteristics and outcomes of patients affected by Charcot neuro-arthropathy (CN) and peripheral arterial disease (PAD) compared to CN without PAD. Consecutive patients presenting with an acute CN were included. The sample size was calculated by the power analysis by adopting the two-tailed tests of the null hypothesis with alfa = 0.05 and a value of beta = 0.10 as the second type error and, therefore, a test power equal to 90%. Seventy-six patients were identified. Twenty-four patients (31.6%) had neuro-ischaemic CN; they were older (66 vs. 57yrs), p = 0.03, had a longer diabetes duration (19 vs. 14yrs), p < 0.001, and more cases of end-stage-renal-disease (12.5 vs. 0%), p = 0.04 and ischaemic heart disease (58.3 vs. 15.4%), p < 0.0001 than neuropathic CN. Fifty patients (65.8%) had concomitant foot ulcers, 62.5% and 67.3% (p = 0.3), respectively, in CN with and without PAD. Neuro-ischaemic CN show arterial lesions of 2.9 vessels, and PAD was located predominantly below-the-knee (75%) but not below-the-ankle (16.7%). The outcomes for neuro-ischaemic and neuropathic CN patients were, respectively: wound healing (86.7 vs. 94.3%), p = 0.08; minor amputation (25 vs. 7.7%), p = 0.003; major amputation (8.3 vs. 1.9%), p = 0.001; hospitalization (75 vs. 23%), p = 0.0001. The study showed a frequent association between CN and PAD, leading to a neuro-ischaemic Charcot foot type. Neuro-ischaemic CN leaded to an increased risk of minor and major amputation and hospitalization, compared to neuropathic CN.
Identifiants
pubmed: 36362457
pii: jcm11216230
doi: 10.3390/jcm11216230
pmc: PMC9656917
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Am Podiatr Med Assoc. 2011 Sep-Oct;101(5):437-46
pubmed: 21957276
Swiss Med Wkly. 2013 Jul 29;143:w13831
pubmed: 23897135
J Foot Ankle Surg. 2016 Jul-Aug;55(4):727-31
pubmed: 27020760
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3266
pubmed: 32176447
Diabetes Care. 2001 Aug;24(8):1433-7
pubmed: 11473082
Diabetes Res Clin Pract. 2017 Jul;129:25-31
pubmed: 28500867
Arch Endocrinol Metab. 2015 Jun;59(3):226-30
pubmed: 26154090
J Clin Med. 2020 Jun 08;9(6):
pubmed: 32521700
Diabetologia. 2008 May;51(5):747-55
pubmed: 18297261
Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:179-217
pubmed: 22271740
J Clin Med. 2020 Nov 21;9(11):
pubmed: 33233329
Diabetes Obes Metab. 2015 May;17(5):435-44
pubmed: 25469642
Diabetes Care. 2009 May;32(5):816-21
pubmed: 19196882
Catheter Cardiovasc Interv. 2015 Oct;86(4):611-25
pubmed: 26256456
Curr Diabetes Rev. 2021;17(4):474-485
pubmed: 33023453
Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):355-69
pubmed: 24486336
Int J Low Extrem Wounds. 2022 Dec;21(4):374-376
pubmed: 33960848
J Cardiovasc Surg (Torino). 2018 Oct;59(5):655-664
pubmed: 29786411
Diabetes Care. 2010 May;33(5):977-82
pubmed: 20200304
Foot Ankle Int. 2017 Feb;38(2):140-148
pubmed: 27923212
J Foot Ankle Surg. 2021 Nov-Dec;60(6):1158-1163
pubmed: 34108117
J Wound Care. 2018 Mar 2;27(3):186-192
pubmed: 29509115
J Chin Med Assoc. 2018 Jun;81(6):565-570
pubmed: 29056486
Diabetes Res Clin Pract. 2019 Jun;152:9-15
pubmed: 31078668
Diabet Med. 1997 May;14(5):357-63
pubmed: 9171250
Diabet Med. 2015 Jun;32(6):760-70
pubmed: 25818542
J Foot Ankle Surg. 2021 Sep-Oct;60(5):941-945
pubmed: 33980466
Diabetes Res Clin Pract. 2016 Jun;116:117-22
pubmed: 27321326
J Wound Care. 2001 Sep;10(8):323-8
pubmed: 12964335
J Wound Care. 2021 Aug 02;30(8):660-664
pubmed: 34382847